<DOC>
	<DOCNO>NCT01062698</DOCNO>
	<brief_summary>THRACE control , multicenter randomize trial . The primary objective study determine whether combined approach intravenous thrombolysis ( IV ) + Mechanical thrombectomy superior reference treatment IV thrombolysis alone , 3 hour onset symptom patient occlusion proximal cerebral artery neurological impairment accident ( National Institutes Health Stroke Scale [ NIHSS ] â‰¥ 10 ) . The second objective determine cost-effectiveness procedure compare standard ( IV thrombolysis ) . The assumption combine approach , improve clinical outcome speed recovery , allow low overall cost IV thrombolysis 3 month less bad neutral 1 year .</brief_summary>
	<brief_title>Trial Cost Effectiveness Evaluation Intra-arterial Thrombectomy Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>10 &lt; =NIHSS Score= &lt; 25 Symptoms onset less 4 hour Occlusion intracranial carotid , middle cerebral artery ( M1 ) upper third basilar Contraindications intravenous thrombolysis Occlusion stenosis preocclusive cervical internal carotid artery ipsilateral lesion Any cause local prohibit femoral catheterization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>mechanical Thrombectomy</keyword>
	<keyword>CVA ( Cerebrovascular Accident )</keyword>
	<keyword>Cerebrovascular Accident , Acute</keyword>
</DOC>